NM_152296.5:c.2839G>C
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PS1_Very_StrongPM2PM5PP2PP3_StrongPP5_Moderate
The NM_152296.5(ATP1A3):c.2839G>C(p.Gly947Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G947W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_152296.5 missense
Scores
Clinical Significance
Conservation
Publications
- alternating hemiplegia of childhood 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- ATP1A3-associated neurological disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- developmental and epileptic encephalopathy 99Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- dystonia 12Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- encephalopathy, acute, infection-inducedInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- alternating hemiplegia of childhoodInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP1A3 | NM_152296.5 | c.2839G>C | p.Gly947Arg | missense_variant | Exon 21 of 23 | ENST00000648268.1 | NP_689509.1 | |
| ATP1A3 | NM_001256214.2 | c.2878G>C | p.Gly960Arg | missense_variant | Exon 21 of 23 | NP_001243143.1 | ||
| ATP1A3 | NM_001256213.2 | c.2872G>C | p.Gly958Arg | missense_variant | Exon 21 of 23 | NP_001243142.1 | ||
| ATP1A3 | XM_047438862.1 | c.2749G>C | p.Gly917Arg | missense_variant | Exon 21 of 23 | XP_047294818.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATP1A3 | ENST00000648268.1 | c.2839G>C | p.Gly947Arg | missense_variant | Exon 21 of 23 | NM_152296.5 | ENSP00000498113.1 | |||
| ENSG00000285505 | ENST00000644613.1 | n.2839G>C | non_coding_transcript_exon_variant | Exon 21 of 25 | ENSP00000494711.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Dystonia 12 Pathogenic:1Other:1
- -
This sequence change replaces glycine with arginine at codon 947 of the ATP1A3 protein (p.Gly947Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with alternating hemiplegia of childhood (PMID: 22842232). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 139579). This variant has been reported to affect ATP1A3 protein function (PMID: 24631656). This variant disrupts the p.Gly947 amino acid residue in ATP1A3. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Alternating hemiplegia of childhood 2 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at